Skip to main content
Caplight Logo









VivaQuant

VivaQuant

Private
Saint Paul, MinnesotaHealthcare & Life Scienceshttps://rhythmexpressecg.com/

Last Round

Angel

Jan 2, 2018

Total Funding Raised

$2.8M

Company Overview

VivaQuant is a digital health company that provides remote cardiac arrhythmia monitoring services and develops wearable cardiac telemetry devices.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

ECG analysiscardiac rhythm monitoringambulatory ECGarrhythmia detectionremote patient monitoringRPMmedical signal processingwearable cardiac monitorclinical decision supportECG softwaretelemetry monitoringdigital healthclinical trial softwareusage-based SaaScardiology AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VivaQuant Comparables

Compare VivaQuant with similar companies based on industry and business-model similarity.

VivaQuant comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AccurKardia
84%
Cardiomatics
82%
InfoBionic.Ai
81%

VivaQuant Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelJan 2, 2018
GrantJan 7, 2016

Key People

Founding team and executive leadership

Marina Brockway

Chief Technology Officer and Founder

Founding Team

Brian Brockway

President and CEO

Executive Team

VivaQuant Investors

Notable investors and investment history

VivaQuant investors
InvestorRounds
National Institutes of Health (NIH)Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors grew 78% MoM, reaching 11.3K.

  • Jun 2, 2025

    Monthly visitors grew 104% MoM, reaching 11.4K.

Recent news

Latest coverage and updates

  • recognized_asAug 7, 2026

    Rhythm Express recognized as 2026 Inc. 5000.

  • recognized_asAug 7, 2026

    Rhythm Express recognized as Inc. list of fastest growing firms.

VivaQuant Filings

Explore SEC and related filing metadata, where available.

VivaQuant filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about VivaQuant's valuation, stock price, and market status.

Is VivaQuant a public or private company?

VivaQuant is a private company.

What is the current stock price of VivaQuant?

VivaQuant is a private company with no public stock price. No recent secondary market data is available.

How much is VivaQuant worth (valuation)?

Valuation information for VivaQuant is not publicly available.

Can I buy VivaQuant stock?

VivaQuant shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was VivaQuant's last funding round?

VivaQuant's most recent funding round was Angel on January 2, 2018.

Who are the main investors in VivaQuant?

Key investors in VivaQuant include National Institutes of Health (NIH).

Will VivaQuant IPO soon?

No public IPO plans have been announced for VivaQuant.

How can I track VivaQuant secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VivaQuant's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSaint Paul, Minnesota
Employee Range57
Year Founded2009
Last FundingJan 2, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?